Genistein: A Potent Anti-Breast Cancer Agent

Smitha S Bhat1, Shashanka K Prasad1, Chandan Shivamallu1

  • 1Department of Biotechnology and Bioinformatics, Faculty of Life Sciences, JSS Academy of Higher Education and Research, Mysuru 570015, Karnataka, India.

Insights

Genistein, a soybean isoflavonoid, exhibits anti-cancer properties by influencing multiple cell signaling pathways. Its effectiveness in cancer treatment is dependent on dosage, timing, and individual patient factors.

Area of Science:

  • Phytochemistry
  • Molecular Biology
  • Oncology

Background:

  • Genistein is a prominent isoflavonoid found abundantly in soybeans.
  • It possesses diverse bioactive properties, making it a subject of intense research for its potential anti-cancer effects.

Purpose of the Study:

  • To investigate the multifaceted mechanisms underlying genistein's anti-cancer activity.
  • To explore the signaling pathways modulated by genistein in controlling cancer cell proliferation.

Main Methods:

  • Review of existing scientific literature on genistein's anti-cancer mechanisms.
  • Analysis of pathways including cell proliferation, tyrosine kinases, Hedgehog-Gli1 signaling, epigenetics, cell cycle, and Akt/MEK pathways.

Main Results:

  • Genistein's anti-cancer effects are mediated through various pathways, including modulation of cell proliferation and signaling cascades.
  • Observed activities are contingent upon specific timeframes and dosages.
  • Genistein's efficacy varies in women, influenced by physiological states like menopausal status.

Conclusions:

  • Genistein demonstrates significant potential as an anti-cancer agent through diverse molecular mechanisms.
  • Further research is warranted to optimize its therapeutic application, considering time, dose, and patient-specific factors.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K